Header Logo

Connection

Stuart Levitz to Amphotericin B

This is a "connection" page, showing publications Stuart Levitz has written about Amphotericin B.
Connection Strength

0.567
  1. Levitz SM, Shoham S, Cleary JD. Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med. 2009 Feb 05; 360(6):634; author reply 635-6.
    View in: PubMed
    Score: 0.315
  2. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism. J Biol Chem. 2003 Sep 26; 278(39):37561-8.
    View in: PubMed
    Score: 0.214
  3. McQuillen DP, Zingman BS, Meunier F, Levitz SM. Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis. 1992 Feb; 14(2):472-8.
    View in: PubMed
    Score: 0.024
  4. Levitz SM, Diamond RD. Changing patterns of aspergillosis infections. Adv Intern Med. 1984; 30:153-74.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.